Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Background: Metabolic acidosis (MA) still remains a very common finding in patients with end stage kidney disease (ESRD) despite the increasing volume of research on dialysis treatment that have resulted in improved haemodialysis delivery. Its occurrence increases the risk of dialysis termination an...
| Format: | Article |
|---|---|
| Published: |
2021
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|